Download Files:
Rentiapril
SKU
HY-106446-10 mg
Category Reference compound
Tags Angiotensin-converting Enzyme (ACE), Cardiovascular Disease, Metabolic Enzyme/Protease
$350 – $2,250
Products Details
Product Description
– Rentiapril is an orally active angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity[1][2].
Web ID
– HY-106446
Storage Temperature
– -20°C (Powder, protect from light, stored under nitrogen)
Shipping
– Blue Ice
Applications
– COVID-19-anti-virus
Molecular Formula
– C13H15NO4S2
References
– [1]Cozens DD, et al. Reproductive toxicity studies of rentiapril. Arzneimittelforschung. 1987 Feb;37(2):164-9.|[2]Ideishi M, et al. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension. Clin Ther. 1989 Jul-Aug;11(4):441-51.
CAS Number
– 80830-42-8
Molecular Weight
– 313.39
Compound Purity
– 99.59
SMILES
– SCCC(N1[C@@H](C2=C(C=CC=C2)O)SC[C@H]1C(O)=O)=O
Clinical Information
– No Development Reported
Research Area
– Cardiovascular Disease
Solubility
– DMSO : 200 mg/mL (ultrasonic)
Target
– Angiotensin-converting Enzyme (ACE)
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.